Search Results

There are 7056130 results for: content related to: Hepatitis C viral infection in difficult-to-treat populations: An overview

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  4. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  5. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  6. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  7. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  8. You have free access to this content
    Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 822–832, Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman, Boris Yoffe, Andrew de la Torre, Steven Flamm, Stuart C. Gordon, Paul Marotta, John M. Vierling, Juan Carlos Lopez-Talavera, Kelly Byrnes-Blake, David Fontana, Jeremy Freeman, Todd Gray, Diana Hausman, Naomi N. Hunder and Eric Lawitz

    Version of Record online : 14 MAY 2010, DOI: 10.1002/hep.23743

  9. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  10. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  11. You have free access to this content
    Hepatitis C genotype 1 infection in HIV–Infected patients in the era of direct-acting antiviral therapy

    Clinical Liver Disease

    Volume 1, Issue 3, July 2012, Pages: 69–72, Mark S. Sulkowski

    Version of Record online : 23 JUL 2012, DOI: 10.1002/cld.51

  12. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1153–1168, Yasuteru Kondo, Yoshiyuki Ueno, Yuta Wakui, Masashi Ninomiya, Eiji Kakazu, Jun Inoue, Koju Kobayashi, Noriyuki Obara and Tooru Shimosegawa

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00878.x

  13. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  14. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950

  15. You have free access to this content
    Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 884–893, Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

    Version of Record online : 17 JUL 2012, DOI: 10.1002/hep.25743

  16. Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment

    Hepatology Research

    Volume 44, Issue 6, June 2014, Pages: 597–607, Tomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, Soo Ryang Kim, Hiroaki Okushin, Masahiko Sugano, Susumu Imoto, Yoshihiko Yano, Teruji Ooka, Yasushi Seo, Hiroshi Kasugai, Akira Muramatsu, Hisato Jomura, Soji Shimomura, Michiko Shindo, Hideji Nakamura, Nobuhiro Aizawa, Yoshinori Iwata, Masaki Saito, Hiroyasu Imanishi, Hiroko Iijma and Shuhei Nishiguchi

    Version of Record online : 30 MAY 2013, DOI: 10.1111/hepr.12153

  17. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  18. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1013–1023, Jean-Michel Pawlotsky, Robert Flisiak, Shiv K. Sarin, Jens Rasenack, Teerha Piratvisuth, Wan-Long Chuang, Cheng-Yuan Peng, Graham R. Foster, Samir Shah, Heiner Wedemeyer, Christophe Hézode, Wei Zhang, Kelly A. Wong, Bin Li, Claudio Avila, Nikolai V. Naoumov and on behalf of the VITAL-1 study team

    Version of Record online : 10 AUG 2015, DOI: 10.1002/hep.27960

  19. You have free access to this content
    Abstracts 624–854

    Hepatology

    Volume 50, Issue S4, 2009, Pages: 600A–705A,

    Version of Record online : 23 SEP 2009, DOI: 10.1002/hep.23303

  20. You have free access to this content
    The new standard of HCV therapy: Retreatment in experienced patients

    Clinical Liver Disease

    Volume 1, Issue 1, February 2012, Pages: 16–19, Naveen Gara and Marc G. Ghany

    Version of Record online : 6 MAR 2012, DOI: 10.1002/cld.4